Renal haemodynamic and excretory responses to bradykinin in anaesthetized dogs

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 8, 1999, Pages 645-650

  Matsumura, Yasuo ^a   Tadano, Kiyoshi ^a   Yamasaki, Tomoyuki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Bradykinin; Bradykinin B2 receptor; Nitric oxide; Prostaglandin; Renal haemodynamics; Urine formation

Indexed keywords

BRADYKININ; BRADYKININ B3 RECEPTOR; ICATIBANT; NITRIC OXIDE; PROSTAGLANDIN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIURESIS; DOG; DRUG EFFECT; ENZYME ACTIVITY; KALLIKREIN KININ SYSTEM; KIDNEY BLOOD FLOW; NONHUMAN; PROSTAGLANDIN SYNTHESIS; SODIUM EXCRETION; TISSUE INJURY; URINARY EXCRETION;

ADRENERGIC BETA-ANTAGONISTS; ANESTHESIA; ANIMALS; BRADYKININ; DOGS; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; HEMODYNAMIC PROCESSES; IBUPROFEN; KIDNEY; MALE; NITROARGININE; URINATION;

EID: 0032770373     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03098.x     Document Type: Article

References (30)

1. Carretero MA, Scicli AG. The renal kallikrein-kinin system. Am. J. Physiol 1980; 238: F247-55.
2. DeFelice AF, Brousseau A. Natriuretic and vasodilating activities of intrarenally administered atriopeptin II, substance P and bradykinin in the dog. J. Pharmacol. Exp. Ther. 1988; 246: 183-8.
3. Siragy HM. Evidence that intrarenal bradykinin plays a role in regulation of renal function. Am. J. Physiol. 1993; 265: E648-54.
4. Lahera V, Salom MG, Fiksen-Olsen MJ, Romero JC. Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradykinin. Am. J. Hypertens. 1991; 4: 260-2.
5. Terragno NA, Lonigro AJ, Malik KU, McGiff JC. The relationship of the renal vasodilator action of bradykinin to the release of a prostaglandin E-like substance. Experientia 1972; 28: 437-9.
6. Regoli D, Rhaleb NE, Drapeau G, Dion DS. Kinin receptor subtypes. J. Cardiovasc. Pharmacol 1990; 15 (Suppl. 6): S30-S38.
7. Farmer SG, Burch RM. The pharmacology of bradykinin receptors. In: Farmer SG (ed.) Bradykinin Antagonists: Basic and Clinical Research. Dekker: New York. 1991; 1-31.
8. 1 receptors: A review. Immunopharmacology 1995; 30: 1-26.
9. Rhaleb NE, Dion S, Barabe J et al. Receptors for kinins in isolated arterial vessels of dogs. Eur. J. Pharmacol. 1989; 162: 419-27.
10. 2-kinin receptors in the renal tubular and hemodynamic response to bradykinin. Am. J. Physiol. 1992; 262: R72-6.
11. Siragy HM, Jaffa AA, Margolius HS. Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide. Hypertension 1997; 29: 757-62.
12. Vurek GG, Pegram SE. Fluorometric method for the determination of nanogram quantities of inulin. Anal. Biochem. 1966; 16: 409-19.
13. Flamenbaum W, Gagnon J, Ramwell P. Bradykinin-induced renal hemodynamic alterations: Renin and prostaglandin relationships. Am. J. Physiol. 1979; 237: F433-40.
14. Beierwaltes WH, Carretero OA, Scicli AG. Renal hemodynamics in response to a kinin analogue antagonist. Am. J. Physiol. 1988; 255: F408-14.
15. Bao G, Qadri F, Stauss B, Stauss H, Gohlke P, Unger T. Hoe 140, a new highly potent and long-acting bradykinin antagonist in conscious rats. Eur. J. Pharmacol. 1991; 200: 179-82.
16. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980; 32: 1-46.
17. Regoli D, Jukic D, Gobell F, Rhaleb N-E. Receptors for bradykinin and related kinin: A critical analysis. Can. J. Physiol. Pharmacol. 1993; 71: 556-67.
18. Toda N, Bian K, Akiba T, Okamura T. Heterogeneity in mechanisms of bradykinin action in canine isolated blood vessels. Eur. J. Pharmacol. 1987; 135:321-7.
19. Yu H, Carretero OA, Juncos LA, Garvin JL. Biphasic effect of bradykinin on rabbit afferent arterioles. Hypertension 1998; 32: 287-92.
20. Guitnaraes JA, Vicira MAR, Camargo MJF, Maack T. Renal vaso-constrictive effect of kinins mediated by B1-kinin receptors. Eur. J. Pharmacol. 1986; 130: 177-85.
21. Matsumura Y, Egi Y, Maekawa H, Miura A, Murata S, Morimoto S. Enhancement of norepinephrine and angiotensin II-induced renal effects by NG-nitro-L-arginine, a nitric oxide syntbase inhibitor. Biol. Pharm. Bull. 1995; 18: 496-500.
22. Egi Y, Matsumura Y, Murata S, Umekawa T, Hisaki K, Morimoto S. The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs. J. Pharmacol. Exp. Ther. 1994; 269; 529-35.
23. Greenberg SS, Dieeke FPJ, Peevy K, Tanaka TP. Endothelium-derived and intraneural nitric oxide-dependent inhibition of norepinephrine efflux from sympathetic nerves by bradykinin. Am. J. Hypertens. 1991; 4: 464-7.
24. Guder WG, Hallbach J. Localization and regulation of the renal kallikrein kinin system: Possible relation to renal transport functions. Klin. Wochenschr. 1988; 66: 849-56.
25. Brenner BM, Falchuk RI, Keimowitz RI, Berliner RW. The relationship between peritubular capillary and fluid reabsorption by the renal proximal tubule. J. Clin. Invest. 1969; 48: 1519-30.
26. Shuster VL, Kokko JP, Jacobson HR. Interaction of L × lysyl-bradykinin and antidiuretic hormone in the rabbit cortical tubule. J. Clin. Invest. 1984; 73: 1659-67.
27. Tomita K, Pisano JJ, Knepper MA. Control of sodium and potassium transport in the cortical collecting duct of the rat. J. Clin. Invest. 1985; 76: 132-6.
28. Carvounis CP, Carvounis G, Arbveit LA. Role of the endogenous kallikrein kinin system modulating vasopressin stimulated water flow and urea permeability in the toad urinary bladder. J Clin. Invest. 1981; 67: 1792-6.
29. Alberola A, Pinilla JM, Quesada T, Romero JC, Salom MG, Salazar FJ. Role of nitric oxide in mediating renal response to volume expansion. Hypertension 1992; 19: 780-4.
30. Smith WL, Sonnenburg WK, Allen ML, Watanabe T, Zhu J, El-Harith EA. The biosynthesis and action of prostaglandins in the renal collecting tubule and thick ascending limb. Adv. Exp. Med. Biol. 1989; 259: 131-47.